8-K - Moleculin Biotech, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Moleculin Biotech, Inc. furnished an investor presentation dated March 19, 2026, under Item 7.01 as Regulation FD Disclosure. The presentation is posted on the Company’s website and included as Exhibit 99.1, which is not deemed 'filed' under the Exchange Act.

Key Takeaways

1Investor presentation dated March 19, 2026, furnished under Item 7.01.

2Exhibit 99.1 contains the corporate presentation used by the Company.

Current Report Details

Event Type

Regulation Fd

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

7.01

of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be “filed” for the purpose of the Securities Exchange Act of 1934,

Regulation Fd

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Investor Presentation dated March 19, 2026 104 Cover page Interactive Data File (f

Exhibits Only

Source Document

Exhibits (2)

8-K

FORM 8-K

99.1

EXHIBIT 99.1